Pharma transactions during the COVID-19 pandemic

Whitepaper front cover

Provided by

Sterling logo

With deal volumes in pharma going against forecasts and rising significantly during the pandemic, this paper takes a close look at how deal flow was maintained during such tough working conditions. Of course, new processes played a big role. But so did the attitudes and resilience of those individuals involved who had to adapt to such unfamiliar conditions.

This paper explores the:

• Use of technology, from zoom to digital signatures

• Subsequent increased scrutiny on cyber security and business continuity

• Impact on contract negotiation, speed of decision making and people

• Post pandemic world and what it could hold for deals in pharma going forward



ITPro is a global business technology website providing the latest news, analysis, and business insight for IT decision-makers. Whether it's cyber security, cloud computing, IT infrastructure, or business strategy, we aim to equip leaders with the data they need to make informed IT investments.

For regular updates delivered to your inbox and social feeds, be sure to sign up to our daily newsletter and follow on us LinkedIn and Twitter.